Adult clinical trials

Beetroot Extract for Health in Adults 75+

This study looks at whether taking beetroot extract can help improve quality of life and daily function in adults 75 and older. You will be asked to take the extract and complete simple health questionnaires.

Autism Treatment Using Stem Cells, Gut Microbiome, and Diet

This study tests whether a combination of stem cell therapy, gut microbiome restoration (using specially prepared stool), and dietary changes can improve autism symptoms, communication, social behavior, and digestive issues. Researchers believe gut health and immune system problems may contribute to autism, and this trial explores whether treating these areas helps.

Better care decisions for adult orphans

This trial seeks to improve medical decisions for adults without family support. It tests a new approach by gathering insights from healthcare workers like doctors, nurses, social workers, and psychologists.

Safety study of DW4421 and DW4421S in healthy adults

This trial tests two forms of a new drug, DW4421 and DW4421S, to see how safe they are and how the body processes them. It is for healthy volunteers aged 19 to 50.

Studying a hip support device for fatigue in older adults

This trial tests a special support device worn on the hips (like a lightweight brace) to see if it can help older adults feel less tired during everyday activities. It may be a simple way to reduce fatigue without extra effort.

Cardiorespiratory fitness in healthy Pakistani adults

This study measures cardiorespiratory fitness in healthy adults aged 18-65 to establish normal values for the Pakistani population. It involves a simple step test and questionnaires to assess your current activity level and overall health.

Exercise and pain processing in healthy adults

This study tests how aerobic exercise affects the way your body processes pain. If you are a healthy adult without chronic pain, you may be able to join.

Social program for older adults in nursing homes

This study tests a social participation program designed to help older adults who live in nursing homes stay connected and engaged. It may help you feel more active and involved in your community.

Airway rod for intubation in adults with obesity

This trial tests if a special rod helps place a breathing tube more easily in adults with obesity who are having planned surgery. It could make the procedure safer and more comfortable.

Long-term follow-up for adults taking Sogroya for growth hormone deficiency

This study follows adults with growth hormone deficiency who start (or have started) Sogroya to learn about its long-term safety. It does not change your treatment—it mainly checks for side effects and health outcomes over time.

Support for parents of young adults with cancer

This study tests a resilience-building program designed to help parents and caregivers of adolescents and young adults (ages 15-39) with cancer feel more supported and manage stress. It may help you find ways to cope and connect with others in similar situations.

Brain scan study for young adults responding to programs

This study uses brain scans and follow-up surveys to understand how young adults respond to programs. It may help if you are a right-handed young adult without a history of brain injury or certain mental health conditions.

Gender Based Comparison of the Effects of Sensory Modulated Graded Weight Bearing Physiotherapy In Adults With Knee Osteoarthritis

Study of LGW16-03 to highlight nerves during surgery

This trial tests a dye called LGW16-03 that may help surgeons see nerves more clearly during open surgery. It is for people who are already scheduled for surgery where a major nerve will be exposed.

Nivolumab plus chemotherapy for early-stage Hodgkin lymphoma in young people

This study tests a combination of a newer immunotherapy drug (nivolumab) with standard chemotherapy (AVD) in children, teens, and young adults with newly diagnosed, early-stage Hodgkin lymphoma—a blood cancer affecting lymph nodes. The goal is to see if adding immunotherapy improves outcomes while being tolerable for this age group.

Blood Thinner Study for Irregular Heartbeat

This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.

Testing new drug combo for first-line extensive small cell lung cancer

This trial tests a new combination treatment (ABBV-706 plus atezolizumab) as a first option for people with extensive stage small cell lung cancer. It compares this new approach to the usual standard treatment, aiming to see if it works better and has fewer side effects.

Baricitinib to delay type 1 diabetes in at-risk people

This trial tests if baricitinib, a pill that calms the immune system, can slow down or delay the onset of type 1 diabetes in children and adults who are at high risk. It is for people whose blood sugar is already starting to rise but who do not yet need insulin.

Study of a drug for ventral hernia repair surgery

This trial tests a study drug (AGN-151607-DP) in adults having open surgery to repair a ventral hernia in the middle of the belly. It looks at side effects and how the hernia responds to treatment.

Multi-Field-Strength MRI Brain Atlas Construction in Healthy Chinese Population

Geriatric assessment for older adults with lung cancer getting SBRT

This study looks at how a geriatric assessment can help older adults with early-stage lung cancer who are getting a precise type of radiation therapy called SBRT. The goal is to understand their needs and improve care.

Triptorelin to protect ovaries in young women with cancer

This study tests whether a medicine called triptorelin can protect the ovaries in young women and teens receiving strong chemotherapy for cancer. If you are newly diagnosed with a cancer (other than breast cancer) and are about to get certain chemotherapy drugs, this trial may help preserve your fertility.

New treatment study for children and young adults with NGGCT brain tumors

This Phase 2 study tests a new treatment approach for certain brain tumors called NGGCT in children and young adults. It may help improve outcomes by targeting tumors in specific brain locations and using tumor marker tests to guide care.

Safety study of REGN22044 in healthy adults

This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.